Paul J Goodfellow - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Paul J Goodfellow

Showing results (71-80 of 113) with videos related to

Pageof 12

Sort By:

Gynecologic Oncology|July 20, 2014

Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.

Cancer|March 2, 2024

Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.

Familial Cancer|August 13, 2009

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndromeIsrael Zighelboim, Matthew A Powell, Sheri A Babb, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 7, 2003

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancersPaul J Goodfellow, Barbara M Buttin, Thomas J Herzog, et al.

Cancer|September 26, 2023

Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.

International Journal of Cancer|January 19, 2007

Evidence for heritable predisposition to epigenetic silencing of MLH1Huiping Chen, Nicholas P Taylor, Kaisa M Sotamaa, et al.

Diseases of the Colon and Rectum|July 2, 2005

Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patientsBrian Y Shin, Huiping Chen, Laura S Rozek, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2013

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational eraCarien L Creutzberg, Henry C Kitchener, Michael J Birrer, et al.

BMC Genomics|October 8, 2014

Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancersBo Zhang, XiaoYun Xing, Jing Li, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2020

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelinePanagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, et al.

Pageof 12

Search research articles

Showing results (71-80 of 113) with videos related to

Sort By:

Pageof 12

Gynecologic Oncology|July 20, 2014

Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.

Cancer|March 2, 2024

Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.

Familial Cancer|August 13, 2009

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndromeIsrael Zighelboim, Matthew A Powell, Sheri A Babb, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 7, 2003

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancersPaul J Goodfellow, Barbara M Buttin, Thomas J Herzog, et al.

Cancer|September 26, 2023

Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.

International Journal of Cancer|January 19, 2007

Evidence for heritable predisposition to epigenetic silencing of MLH1Huiping Chen, Nicholas P Taylor, Kaisa M Sotamaa, et al.

Diseases of the Colon and Rectum|July 2, 2005

Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patientsBrian Y Shin, Huiping Chen, Laura S Rozek, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2013

BMC Genomics|October 8, 2014

Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancersBo Zhang, XiaoYun Xing, Jing Li, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2020

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelinePanagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, et al.

Pageof 12